Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1593-1601

  Redlberger Fritz, M ^a   Aberle, S W ^a   Strassl, R ^a   Popow Kraupp, T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE; SIALIDASE INHIBITOR; ANTIVIRUS AGENT; NA PROTEIN, INFLUENZA A VIRUS; VIRUS PROTEIN; VIRUS RNA;

2009 H1N1 INFLUENZA; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MELTING POINT; MUTATIONAL ANALYSIS; NEURAMINIDASE GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SEQUENCE ANALYSIS; VIRUS GENE; DRUG EFFECT; EVALUATION; GENETICS; GENOTYPE; HUMAN; METHODOLOGY; MISSENSE MUTATION; TRANSITION TEMPERATURE; VIROLOGY;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENOTYPE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MUTATION, MISSENSE; NEURAMINIDASE; RNA, VIRAL; TRANSITION TEMPERATURE; VIRAL PROTEINS; VIROLOGY;

EID: 84865582474     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1482-9     Document Type: Article

References (31)

1. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS (2002) Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347(26):2097-2103. doi:10.1056/NEJMoa020546
2. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA (1997) Influenza virus infections in infants. Pediatr Infect Dis J 16 (11):1065-1068
3. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342(4):232-239. doi:10.1056/NEJM200001273420402
4. Sullivan KM, Monto AS, Longini IM Jr (1993) Estimates of the US health impact of influenza. Am J Public Health 83(12):1712-1716
5. World Health Organization (WHO) (2005) Influenza fact sheet
6. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG (2001) Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 183 (4):523-531. doi:10.1086/318537
7. Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297 (13):1435-1442. doi:10.1001/jama.297.13.1435
8. Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S (2007) Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 55(3):267-272. doi:10.1016/j. jinf.2007.05.176
9. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y (2004) Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet 364(9436):759-765. doi:10.1016/S0140-6736 (04)16934-1
10. Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M (2009) Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis 48 (4):389-396. doi:10.1086/596311
11. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 15(2):155-162
12. Lackenby A, Hungnes O, Dudman SG,Meijer A, PagetWJ, Hay AJ, Zambon MC (2008) Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 13(5):pii:8026
13. Wong SS, Yuen KY (2008) Antiviral therapy for respiratory tract infections. Respirology 13(7):950-971. doi:10.1111/j.1440-1843.2008.01404.x
14. Gubareva LV (2004) Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 103(1-2):199-203. doi:10.1016/j.virusres. 2004.02.034
15. Tisdale M (2000) Monitoring of viral susceptibility: New challenges with the development of influenza NA inhibitors. Rev Med Virol 10(1):45-55. doi:10.1002/(SICI)1099-1654 (200001/02)10:1<45::AID-RMV265>3.0.CO;2-R
16. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50(7):2395-2402. doi:10.1128/AAC.01339-05
17. Wetherall NT, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin JL, Zambon M, Hayden FG (2003) Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: Report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 41(2):742-750
18. Göhring K, Mikeler E, Jahn G, Hamprecht K (2006) Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance. J Clin Microbiol 44(12):4541-4544. doi:10.1128/ JCM.01141-06
19. Redlberger M, Aberle SW, Heinz FX, Popow-Kraupp T (2007) Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/ 2003 to 2004/2005) in Austria. Vaccine 25(32):6061-6069. doi:10.1016/j.vaccine.2007.05.045
20. Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC (2004) Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 42(4):1564-1569
21. Overduin P, Jenny S, Meijer A (2011) Influenza A PCR Light Cycler -probe test A-matrix-B-NS-H1-H1v-H3-H5-N1-N1v-N1avian-N2. RIVM Laboratory Protocol Library document; https://extranet.ecdc.europa.eu/EISN/Shared%20Documents/ Document%20library%20and%20past%20meetings/CNRL%20library/ Laboratory%20Protocol%20Library/Molecular%20Detection/Influenza-diagnostic-qPCR- RIVM-2011.pdf
22. World Health Organization (WHO) (2010) WHO External Quality Assessment Programme for the Detection of Influenza Virus Type A by PCR, Summary Report Panel 7 (January-March 2010)
23. Duwe S, Schweiger B (2008) A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Methods 153 (2):134-141. doi:10.1016/j.jviromet. 2008.07.017
24. Guo L, Garten RJ, Foust AS, Sessions WM, Okomo-Adhiambo M, Gubareva LV, Klimov AI, Xu X (2009) Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay. Antiviral Res 82(1):29-33. doi:10.1016/j.antiviral.2009.01. 004
25. Mahony JB, Chong S, Luinstra K, Petrich A, Smieja M (2010) Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses. J Clin Virol 49(4):277-282. doi:10.1016/j.jcv.2010.08.006
26. Wong S, Pabbaraju K, Wong A, Fonseca K, Drews SJ (2011) Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes. J Virol Methods 173(2):259-265. doi:10.1016/j.jviromet.2011.02.014
27. Bolotin S, Robertson AV, Eshaghi A, De Lima C, Lombos E, Chong-King E, Burton L, Mazzulli T, Drews SJ (2009) Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates. J Virol Methods 158(1-2):190-194. doi:10.1016/j. jviromet.2009.01.016
28. Carr MJ, Sayre N, Duffy M, Connell J, Hall WW (2008) Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses. J Virol Methods 153(2):257-262. doi:10.1016/j. jviromet.2008.07.011
29. Operario DJ, Moser MJ, St George K (2010) Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus. J Clin Microbiol 48(10):3517-3524. doi:10.1128/JCM. 01031-10
30. van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M (2010) Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol 47(1):34-37. doi:10.1016/j.jcv.2009.09.030
31. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52(9):3284-3292. doi:10.1128/AAC.00555-08